Navigation Links
Mindray Announces 2008 Fourth Quarter and Full Year Results
Date:3/4/2009

et revenues generated in international markets in the fourth quarter 2008 increased 103.9% to $95.2 million from $46.7 million for the fourth quarter 2007, while net revenues generated in China in the fourth quarter 2008 increased 63.6% to $72.7 million from $44.4 million for the fourth quarter 2007.

Performance by Segment

Patient Monitoring & Life Support Products: Patient monitoring & life support products segment revenues increased 151.1% to $77.9 million from $31.0 million for the fourth quarter 2007. The patient monitoring & life support products segment contributed 46.8% to the total net segment revenues in the fourth quarter 2008.

In-Vitro Diagnostic Products: In-vitro diagnostic products segment revenues increased 34.3% to $36.4 million from $27.1 million in the fourth quarter 2007. The in-vitro diagnostic products segment contributed 21.9% to the total net segment revenues in the fourth quarter 2008.

Medical Imaging Systems: Medical imaging systems segment revenues increased 40.8% to $42.6 million from $30.3 million in the fourth quarter 2007. The medical imaging systems segment contributed 25.6% to the total net segment revenues in the fourth quarter 2008.

Others: The other revenues which are primarily comprised of extended warranty services revenues and revenues derived from the third party R&D projects increased 564.9% to $9.4 million from $1.4 million in the fourth quarter 2007. The other revenues contributed 5.7% to the total net segment revenues in the fourth quarter 2008.

The segment revenue amounts discussed above exclude the shipping and handling fees charged to customers.

Gross Margins

Fourth quarter 2008 gross profit was $91.1 million, an 88.6% increase from $48.3 million in the fourth quarter 2007. The consolidated gross margin for the fourth quarter 2008 was 54.3% compared to 53.0% in the fourt
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Mindray Medical International Announces Second Quarter 2008 Results
2. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
3. Mindray Medical International Announces First Quarter 2008 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces Third Quarter 2007 Results
6. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
7. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
8. Martek Announces First Quarter 2009 Financial Results
9. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors
10. STAAR Surgical Announces Fourth Quarter and Full Year 2008 Earnings Release Date and Conference Call
11. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  For people with Down syndrome, ... day. The biotechnology company, located in the Science + ... the best potential therapies yet for people with Down syndrome ... Correction of Down syndrome and Edwards syndrome aneuploidies in ... DNA Research . Elixirgen plans to develop this technology ...
(Date:8/31/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 31, 2015 ... on the discovery and development of novel cancer immunotherapies, ... , M.D., Ph.D., as Chief Executive Officer and ... Drs. Wong and Ho join an experienced management team ... company: Jordan Fridman , Ph.D., Chief Scientific Officer; ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... There’s a ... Minerva is the first commercially available new FDA approved system in the last ... rate of 92%, the high Amenorrhea (zero bleeding) rate of 66%, the high Patient ...
(Date:8/28/2015)... ... August 28, 2015 , ... Proove Biosciences ... the International Spine Intervention Society’ s 23rd Annual Scientific Meeting (ASM). ... 2015. With a focus on evidence-based research and clinical application, the event gathered ...
Breaking Biology Technology:New Down syndrome therapy discovered 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4
... SAN DIEGO, April 28, 2011 Genomatica ... Chemical Corporation , the eighth-largest chemical maker in the world, ... areas of collaboration.  These include: , Study of ... production in Asia :  Mitsubishi and Genomatica ...
... Qteros, Inc., the developer of a unique and highly ... lowest-cost production of cellulosic ethanol, today announced its plans ... of May. Kevin A. Gray, Ph.D., Senior ... deliver an oral presentation at the 33rd Symposium on ...
... The Center for Business Intelligence (CBI), a division of ... Children,s Rare Disease Network and The Global Genes Project for ... 12 - 13, 2011 at the Doubletree Hotel in Washington, ... They affect few people individually, but there are more than ...
Cached Biology Technology:Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia 2Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia 3Qteros Management to Present at Upcoming Conferences in May 2CBI Announces Partnership With Children's Rare Disease Network and The Global Genes Project 2CBI Announces Partnership With Children's Rare Disease Network and The Global Genes Project 3
(Date:7/31/2015)... La 10 th International Conference on Genomics ... 22 al 25 de octubre de 2015 en ... conferencia celebra su décimo aniversario. Desde su inauguración en el ... reuniones anuales más influyentes del mundo en el campo ,ómico, ... y mejores a nivel científico. ICG-10 se ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 ... products and services for gene function analysis and ... CRISPR Guide RNA (sgRNA) Knockout Library targeting all ... to specifically and permanently "knock out" a gene,s ... library provides a high throughput screening tool so ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... Genome Project at Penn State University, with an ... to Charles Darwin's "abominable mystery:" the inexplicably rapid ... appearance some 140 million years ago. By ... sequences from thirteen strategically selected plant species, the ...
... an important role in the formation of gold nuggets ... in the international journal, Science .. , The ... for Landscape Environments and Mineral Exploration (CRC LEME) project ... has shown that bacteria play a significant role in ...
... Medical School researchers have discovered one way that a ... of chronically infected cystic fibrosis (CF) patients. ... as Pseudomonas aeruginosa (PA) use protein secretion systems to ... author of the study published in the June 9 ...
Cached Biology News:Massive duplication of genes may solve Darwin's 'abominable mystery' about flowering plants 2Massive duplication of genes may solve Darwin's 'abominable mystery' about flowering plants 3Massive duplication of genes may solve Darwin's 'abominable mystery' about flowering plants 4The Midas Bug -- the bacterial alchemy of gold 2Discovery could aid fight against cystic fibrosis infection 2
Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297...
This application changes sensitive keywords in an FCS file to remove patient information. It was contributed by Dr. David Miller....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: